West Palm Beach, Florida, May 14, 2026, 09:02 EDT
Quantum Cyber N.V. has brought Peter M. O’Rourke Sr.—the former acting U.S. Veterans Affairs Secretary and military vet—onto its board, the company said Thursday. The appointment comes on the heels of Wednesday’s announcement of a drone tech licensing deal by the Nasdaq-listed firm. CEO David Lazar described the move as a “defining moment.” For his part, O’Rourke said autonomous defense systems are “rapidly becoming foundational.” GlobeNewswire
Traders wasted no time. QUCY last showed at $1.34 ahead of the bell. According to Investing.com, the token’s up 264% over the week, putting its market cap near $16.8 million—a surge built on a tiny foundation.
This is the crux right now. Quantum Cyber wants to pivot quickly away from its Mainz Biomed roots and into defense tech. Shareholders greenlit the rebrand to Quantum Cyber N.V. back in April, according to a filing. David Lazar now controls over 95% of the voting rights on a fully diluted basis.
Quantum Cyber on Wednesday announced it had reached an intellectual-property license agreement with BP United Inc., a Miami-based developer specializing in autonomous unmanned vehicle systems. Under the deal, Quantum Cyber secures exclusive rights to BP United’s entire drone lineup, highlighted by the “sky defense” platform—claimed range over 25 km, autonomous launch and landing, encrypted comms. CFO Bill Caragol said the agreement sets up both an “exclusive intellectual property position” and a “commercial supply chain.” GlobeNewswire
No coincidence in the schedule. The fiscal 2027 U.S. defense budget outline earmarks $53.6 billion for autonomous systems—buying, producing, and developing new tech at home. Another $20.6 billion shows up for counter-drone tools. Counter-UAS—counter-unmanned aerial systems—means gear built to spot, track, or knock out drones.
Quantum Cyber is stepping into a packed arena. Red Cat Holdings landed the U.S. Army’s Short Range Reconnaissance small drone contract, and earlier this month, AeroVironment announced the Army had chosen its Switchblade 400 — a loitering munition capable of circling targets before striking — for the LASSO program.
Quantum Cyber is still in the early stages here. The company calls its product a “System-of-Systems” platform, military lingo for tying together different pieces — drones, counter-drone gear, demining kits, command-and-control — into a unified network.
The numbers tell the story. Mainz Biomed’s 2025 annual report listed revenue at just $537,080, with a steep net loss of $16.2 million. Year-end cash stood at $889,091. According to the filing, ongoing losses and negative working capital were serious enough to cast “substantial doubt” on the company’s ability to stay in business. SEC
Dilution is back on the table. In May, Quantum Cyber tweaked its equity distribution deal with Maxim Group, bumping the ceiling for ordinary share sales under the arrangement to $100 million—up sharply from the previous $10 million.
The company isn’t chasing trends in drones. The real question is if BP United’s tech can actually make it through production, land government or allied buyers, and still attract capital—without sidelining current holders.
At this stage, QUCY remains a small and volatile Nasdaq stock, buoyed by two connected moves: a shift toward defense and the addition of a board member with Washington clout to back it up. What investors look for next—actual contracts, products shipped, and top-line results.
